
RXRX vs TARS
$RXRX vs $TARS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RXRX vs TARS: the quick read
- ·TARS is the larger company by market cap ($3.26B vs $1.82B).
- ·RXRX has been more active on our scanner (259 vs 70 alerts in 30 days).
- ·TARS has the smaller float (39.4M vs 535.3M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: RXRX is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·RXRX draws far more of our scanner's attention, 259 unusual-volume alerts in 30 days against 70, so it is the more actively traded of the two by some distance.
- ·They have diverged badly over the year: TARS is near the top of its 52-week range while RXRX is near the bottom of its own.
- ·TARS is the one in play today, trading about 2.5x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RXRX and TARS on TheDesperateTrader.
- Is RXRX or TARS the better stock?
- "Better" depends on your goal, and these two are not alike. TARS is the larger company by market cap ($3.26B vs $1.82B). RXRX has been more active on our scanner (259 vs 70 alerts in 30 days). TARS has the smaller float (39.4M vs 535.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RXRX and TARS?
- The differences that matter: they are similar in size ($1.82B vs $3.26B); they trade at very different share prices ($3.30 vs $82.46); RXRX sits at 12% of its 52-week range against 92% for TARS; our scanner flagged RXRX 259 times in the last 30 days against 70 for TARS. Everything above is measured from the latest completed session and SEC filings.
- Which of RXRX and TARS is more active right now?
- Right now RXRX is at about 0.9x its normal volume and TARS is at about 2.5x, so TARS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RXRX or TARS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore RXRX and TARS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.